NEW YORK CITY

Genzyme Shares Hit New High Again

A sign marks the headquarters of Genzyme in Cambridge
Genzyme Corp. (NASDAQ: GENZ) said Monday that its board has unanimously recommended to its shareholders to accept the latest sweetened offer from French drug giant Sanofi-Aventis SA (NYSE: SNY) and to tender their shares into the revised offer. The shares of Genzyme touched a new 52-week high of $76.09 on Wednesday.
IBTimes Logo

NYSE faces tough fight with CME, CFO says

NYSE Euronext's planned assault this month on CME Group Inc's flagship U.S. rate futures franchise will be tough going because traders value liquidity, CME Chief Financial Officer Jamie Parisi said on Wednesday.
More news
IBTimes Logo

Latest video of Sept 9/11 attack emerges

A latest video of the 2001 Sept 11 attacks on World Trade Centre has surfaced, which is shot from a police helicopter hovering near the burning World Trade Center towers in the hope of rescuing survivors.
Taiwan AIG unit bidders set to face regulators

Taiwan AIG unit bidders set to face regulators

Shareholders of two of the firms in a consortium buying U.S. insurer AIG's Taiwan unit approved the $2.16 billion bid on Wednesday, setting the scene for what is expected to be a tough battle with regulators.
A man leans against a wall to read his newspaper before entering the subway in Grand Central Station in New York

Manhattan loses jobs as outer boroughs grow: study

Manhattan lost nearly 110,000 jobs from 2000 to 2009 while its outer boroughs were gaining jobs, thanks to the growth of two sectors, education and healthcare, a think tank's report said on Wednesday.
A pedestrian walks past the NASDAQ building in New York City

Nasdaq mulls NYSE bid in exchange deal dash

Nasdaq OMX Group Inc could launch a rival bid for NYSE Euronext to avoid being left on the sidelines, a source said, as traditional exchanges race to merge to see off upstart electronic rivals.

Pages

IBT Spotlight

We Help Businesses Find B2B Service Providers They Can Trust.